The Bronchial Spasm market size is expected to reach $5.35 billion in 2030 at a CAGR of 7.0%, driven by increasing prevalence of respiratory diseases.
Read More
The Bioprocess Digital Twin market size is expected to reach $4.88 billion in 2030 at a CAGR of 24.6%, driven by expanding biopharmaceutical production.
Read More
The Biologics Sterile Fill-Finish Services market size is expected to reach $8.35 billion in 2030 at a CAGR of 10.7%, driven by rising biosimilar approvals.
Read More
The Biologics Active Pharmaceutical Ingredient (API) market size is expected to reach $101.84 billion in 2030 at a CAGR of 8.8%, driven by increasing personalized medicine demand.
Read More
The Bioconjugation market size is expected to reach $11.12 billion in 2030 at a CAGR of 12.7%, driven by rising targeted therapeutics demand.
Read More
The Arrayed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Screening market size is expected to reach $3.43 billion in 2030 at a CAGR of 17.7%, driven by increasing focus on personalized medicine.
Read More
The Antibiotics Active Pharmaceutical Ingredient (API) market size is expected to reach $44.5 billion in 2030 at a CAGR of 11.1%, driven by rising prevalence of bacterial infections.
Read More
The recombinant vaccines market is projected to reach $28.07B by 2030 at 12.2% CAGR, driven by precision vaccines, emerging disease programs, adult boosters, and advanced recombinant platforms.
Read More
The recombinant proteins manufacturing services market is projected to reach $7.12B by 2030 at 14% CAGR, driven by protein therapeutics pipelines, pharma outsourcing, and GMP bioprocessing demand.
Read More
The recombinant human GCSF injection market is projected to reach $5.86B by 2030 at 8.6% CAGR, driven by cancer care demand, biosimilar adoption, and long-acting injectables.
Read More